Literature DB >> 10658169

The molecular diagnosis of metabolic myopathies.

G D Vladutiu1.   

Abstract

The metabolic myopathies are distinguished by extensive clinical and genetic heterogeneity within and between individual disorders. There are a number of explanations for the variability observed that go beyond single gene mutations or degrees of heteroplasmy in the case of mitochondrial DNA mutations. Some of the contributing factors include protein subunit interactions, tissue-specificity, modifying genetic factors, and environmental triggers. Advances in the molecular analysis of metabolic myopathies during the last decade have not only improved the diagnosis of individual disorders but also helped to characterize the contributing factors that make these disorders so complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10658169     DOI: 10.1016/s0733-8619(05)70179-1

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  2 in total

Review 1.  The clinical laboratory evaluation of the patient with noninflammatory myopathy.

Authors:  R L Wortmann; G D Vladutiu
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

2.  Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency.

Authors:  I Hamilton-Craig; M Yudi; L Johnson; R Jayasinghe
Journal:  Case Rep Med       Date:  2012-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.